Skip to main content
NC Medicaid logo NC Medicaid

Topical Navigation

  • Home
  • Beneficiaries
  • Meetings & Notices
  • Find a Doctor
  • Providers
  • Counties
  • Reports
  • ABOUT US
  • NC.GOV
  • NCDHHS
  • SERVICES
NC Medicaid »   Providers »   Medicaid Bulletin

Medicaid Bulletin

Medicaid Bulletin Monthly Digest

Medicaid Bulletin Archive

Articles beginning January 2018 are available in the blog format.

SPECIAL BULLETIN COVID-19 #244: Evusheld Alternative to COVID-19 Vaccination for Some Patients
Thursday, April 21, 2022

Billing Guideline for use of Evusheld

Research Based – Behavioral Health Treatment for Autism Spectrum Disorder
Tuesday, April 19, 2022

Approved for beneficiaries over the age of 21, effective July 1, 2021

Reminder: As the Federal Public Health Emergency Ends, Provider Reverification Requirements are Reinstated
Tuesday, April 19, 2022

With the end of the federal Public Health Emergency (PHE) expected in the Summer of 2022, NC Medicaid providers will begin receiving reverification notices.

NCCI/MUE Edits for ALL PADP Drug Claims
Tuesday, April 19, 2022

The Medicaid NCCI edits for the most recent quarter are published on the CMS website.

Additional NC Innovations Funding and Innovations Waiver Clinical Coverage Policy Updated
Tuesday, April 19, 2022

NC Medicaid received approval to increase NC Innovations Waiver capacity by 1,000 slots.

Tebentafusp-tebn Injection, for Intravenous Use (Kimmtrak®) HCPCS Code J9999: Billing Guidelines
Tuesday, April 12, 2022

Effective with date of service Feb. 25, 2022, the Medicaid and NC Health Choice programs cover tebentafusp-tebn injection.

Sirolimus Protein-Bound Particles for Injectable Suspension (Albumin-Bound), for Intravenous Use (Fyarro™) HCPCS Code J9999: Billing Guidelines
Tuesday, April 12, 2022

Effective with date of service Feb. 23, 2022, the Medicaid and NC Health Choice programs cover sirolimus protein-bound particles for injectable suspension (albumin-bound).

Plasminogen, Human-tvmh Lyophilized Powder for Reconstitution, for Intravenous Use (Ryplazim®) HCPCS Code J3590: Billing Guidelines
Tuesday, April 12, 2022

Effective with date of service March 2, 2022, the Medicaid and NC Health Choice programs cover plasminogen, human-tvmh lyophilized powder for reconstitution.

Naloxone Hydrochloride Injection for Intramuscular or Subcutaneous use (Zimhi™) HCPCS code J3490: Billing Guidelines
Tuesday, April 12, 2022

Effective with date of service March 15, 2022, the Medicaid and NC Health Choice programs cover naloxone hydrochloride injection for intramuscular or subcutaneous use.

Home Health Services Electronic Visit Verification Implementation
Tuesday, April 12, 2022

EVV for Home Health in January 2023

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Share this page:

  • Facebook
  • Twitter
  • Email
Back to top

Contact Information

NC Medicaid
Division of Health Benefits

2501 Mail Service Center
Raleigh, NC 27699-2501
 
NC Medicaid Contact Center
Phone: 888-245-0179
Monday-Friday 8 a.m. to 5 p.m.
Closed on State holidays. 
 
Visit RelayNC for information about TTY services. 
 
More
 

Recent Tweets

Tweets by @ncdhhs

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • EMPLOYEE DIRECTORY
  • TRANSLATION DISCLAIMER
  • Accessibility
  • Terms of Use
  • Privacy Policy
  • Open Budget
NC Medicaid
https://medicaid.ncdhhs.gov/providers/medicaid-bulletin